Rationale and Design of ATHENA: A Placebo-Controlled, Double-Blind, Parallel Arm Trial to Assess the Efficacy of Dronedarone 400 mg Bid for the Prevention of Cardiovascular Hospitalization or Death from Any Cause in PatiENts with Atrial Fibrillation/Atrial Flutter

Background: Atrial fibrillation (AF) is the most commonly encountered clinical arrhythmia, predominantly affecting elderly patients. There is a continued need for new antiarrhythmic drugs to treat the ever‐increasing number of patients with this arrhythmia. Dronedarone is a new antiarrhythmic compou...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of cardiovascular electrophysiology Vol. 19; no. 1; pp. 69 - 73
Main Authors:	HOHNLOSER, STEFAN H., CONNOLLY, STUART J., CRIJNS, HARRY J.G.M., PAGE, RICHARD L., SEIZ, WERNER, TORP-PETERSEN, CHRISTIAN
Format:	Journal Article
Language:	English
Published:	Malden, USA Blackwell Publishing Inc 01-01-2008
Subjects:	Amiodarone - analogs & derivatives Amiodarone - therapeutic use Anti-Arrhythmia Agents - administration & dosage antiarrhythmic drugs atrial fibrillation Atrial Fibrillation - mortality Atrial Fibrillation - prevention & control cardiovascular hospitalization Double-Blind Method dronedarone Hospitalization - statistics & numerical data Humans Internationality mortality Placebo Effect Randomized Controlled Trials as Topic Risk Assessment - methods Risk Factors Survival Analysis Survival Rate Treatment Outcome
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!